tirzepatide and osteoarthritis Trending now at Annals.org: Both #semaglutide #tirzepatide were cost-effective compared to usual care for people with knee and obesity, but gave a better return on investment Tirzepatide More Cost-Effective Than Semaglutide

The manufacturing layer protects how the molecule is made at scale

The FDA later recommended against approving ipamorelin for compounding

Nicolas Rasmussen: Methamphetamines out there too

doi:10.1001/jama.2019.13772 Lau J, Bloch P, Schffer L, et al

The goal is creating a record that removes guesswork from your dosing decisions

What many people don't realize is just how strongly sleep apnea and body weight are connected: Approximately 40% of people with obesity have significant sleep apnea Around 70% of sleep apnea patients are classified as obese A mere 10% increase in body weight can increase your sleep apnea risk sixfold Conversely, losing just 10% of your body weight can dramatically decrease sleep apnea severity This strong relationship explains why weight loss has always been recommended for sleep apnea management